Anavex Life Sciences (NASDAQ:AVXL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Anavex Life Sciences (AVXL) operate in?

Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Anavex Life Sciences Stock (NASDAQ: AVXL) stock price, news, charts, stock research, profile.

Open	$8.54
Close	$8.52
Volume / Avg.	839.08K / 1.80M
Day Range	$8.45 - $8.95
52 Wk Range	3.25 - 14.44
Market Cap	$716.89M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	28.49%
Days to Cover	17.39

Recent News

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New York.

Piero Cingari

Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday

Avi Kapoor

Short-Squeeze Target Anavex Life Sciences Gains Traction

Anavex Life Sciences (NASDAQ:AVXL) is a short-squeeze candidate because its share prices are rising on good news, institutional and analyst support is growing, and the short-sellers are selling into the rally. Short

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.54
Close	$8.52
Volume / Avg.	839.08K / 1.80M
Day Range	$8.45 - $8.95
52 Wk Range	3.25 - 14.44
Market Cap	$716.89M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	28.49%
Days to Cover	17.39

About Anavex Life Sciences Corporation

Sector

Health Care

Industry

Biotechnology

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development o...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Anavex Life Sciences (AVXL) stock?

You can purchase shares of Anavex Life Sciences (NASDAQ:AVXL) through any online brokerage.

View our list of the best stock brokerages

Who are Anavex Life Sciences (AVXL) competitors?

Other companies in Anavex Life Sciences’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Anavex Life Sciences (AVXL) stock?

Anavex Life Sciences has a consensus price target of $35.50.

What is the current price for Anavex Life Sciences (AVXL)?

The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $8.4523 last updated February 14, 2025 at 6:30 PM EST.

Does Anavex Life Sciences (AVXL) pay a dividend?

There are no upcoming dividends for Anavex Life Sciences.

When is Anavex Life Sciences (NASDAQ:AVXL) reporting earnings?

Anavex Life Sciences’s Q2 earnings are confirmed for Thursday, May 8, 2025.

Is Anavex Life Sciences (AVXL) going to split?

There is no upcoming split for Anavex Life Sciences.

What sector and industry does Anavex Life Sciences (AVXL) operate in?

Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Anavex Life Sciences

Anavex Life Sciences (AVXL) Forecast